IgG4-Related Disease: Beyond Glucocorticoids.

Area of Science:

• Immunology
• Rheumatology
• Pathology

Background:

• IgG4-related disease (IgG4-RD) is a complex fibroinflammatory condition impacting various organs, predominantly in individuals over 60.
• Accurate diagnosis requires excluding other serious conditions like malignancies and vasculitis.
• Current treatment relies on glucocorticoids, which pose risks in elderly patients with comorbidities.

Purpose of the Study:

• To review the pathophysiology and clinical characteristics of IgG4-related disease.
• To highlight emerging therapeutic targets and glucocorticoid-sparing strategies for IgG4-RD management.

Main Methods:

• Literature review of IgG4-related disease pathophysiology.
• Analysis of clinical characteristics and treatment outcomes.
• Identification of potential therapeutic targets.

Main Results:

• IgG4-RD involves specific immune cells including T follicular helper cells, CD4+ cytotoxic T cells, plasmablasts, and M2 macrophages.
• Glucocorticoid therapy is standard but associated with significant side effects in the elderly population.
• Alternative immunosuppressants and targeted immunomodulators show promise as steroid-sparing or maintenance treatments.

Conclusions:

• Understanding IgG4-RD pathophysiology is key to developing targeted therapies.
• Glucocorticoid-sparing agents are crucial for managing IgG4-RD, especially in older patients.
• Further research into novel immunomodulators and targeted therapies is warranted for effective IgG4-RD treatment.